Position in EVGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,746
-$144 QoQ
Shares Held
10,790
+69.9% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 13 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in EVGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,747,178,871 across 561 Biotechnology names. EVGN ranks #473 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in EVGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,746 | 10,790 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,890 | 6,352 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,316 | 1,197 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,368 | 1,201 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,613 | 6,729 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,430 | 18,745 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $41,162 | 22,012 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,405 | 8,601 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,903 | 66,005 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $46,871 | 62,495 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $47,044 | 56,005 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $21,242 | 36,005 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $31,053 | 29,023 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $13,233 | 21,005 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,729 | 21,043 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $14,560 | 17,543 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $11,168 | 14,505 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $46,493 | 35,765 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $89,432 | 54,532 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,229 | 14,481 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $120,582 | 35,258 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $139,451 | 27,669 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $128,996 | 27,446 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $513,480 | 129,667 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $316,069 | 316,069 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,601,566 | 1,357,260 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||